Hopman Mark sold BBNX
March 4, 2026 · Form 4 insider transaction
Hopman Mark sold 353 shares of Beta Bionics, Inc. at $11.57 per share, a transaction worth $4.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
353
Price
$11.57
Total value
$4.1K
InsiderHopman Mark
RoleOfficer
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 4, 2026
Filing dateMarch 5, 2026
Shares owned after139,133
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025.